NewsStocksJHS Svendgaard Laboratories Reappoints Nikhil Nanda as Managing Director, Approves Key AppointmentsJHS Svendgaard Laboratories Reappoints Nikhil Nanda as Managing Director, Approves Key Appointments
JHS Svendgaard Laboratories Limited held its 21st AGM on September 20, 2025, making several important decisions. Shareholders approved the reappointment of Nikhil Nanda as Managing Director for a five-year term starting July 2, 2025. The company appointed M/s V.K. Khosla & Co as Statutory Auditors and M/s Dahiya & Associates as Secretarial Auditors, both for five-year terms. Mr. Vinay Mittal was appointed as a Director. The JHS Svendgaard Laboratories Limited - Employee Stock Option Scheme 2025 was also approved. Key resolutions, including financial statement adoption, passed with over 99% votes in favor.
*this image is generated using AI for illustrative purposes only.
JHS Svendgaard Laboratories Limited , a prominent player in the FMCG industry, has announced significant leadership and governance decisions following its 21st Annual General Meeting (AGM) held on September 20, 2025.
Nikhil Nanda's Reappointment
The company's shareholders have approved the reappointment of Nikhil Nanda as Managing Director for a five-year term. Nanda's new tenure will commence on July 2, 2025, and continue until the conclusion of the 26th AGM in 2030.
Leadership Profile
Nikhil Nanda, a first-generation entrepreneur, brings over 30 years of experience in the FMCG sector to his role. He holds a Business Management degree with double majors in Finance and Marketing from FORE School of Management, New Delhi. Nanda's entrepreneurial journey began in 1997 when he founded the company, which he successfully took public in 2006 with a $10 million IPO.
Corporate Governance
JHS Svendgaard Laboratories has emphasized its commitment to strong corporate governance by making several key appointments:
Statutory Auditors: M/s V.K. Khosla & Co, Chartered Accountants (FRN: 002283N), have been appointed for a five-year term until the 26th AGM in 2030.
Secretarial Auditors: M/s Dahiya & Associates, Practicing Company Secretaries (Peer Review certificate No. 6772/2025), have also been appointed for a five-year term until the 26th AGM in 2030.
Director Appointment: Mr. Vinay Mittal (DIN: 08232559) has been appointed as a Director, liable to retire by rotation.
Employee Stock Option Scheme
In a move that could potentially align employee interests with company performance, the shareholders have approved the JHS Svendgaard Laboratories Limited - Employee Stock Option Scheme 2025.
AGM Highlights
The 21st AGM, conducted through video conferencing, saw active participation from shareholders. Key resolutions, including the adoption of audited standalone and consolidated financial statements for the year ended March 31, 2025, were passed with overwhelming majority.
| Resolution | Votes in Favor (%) | Votes Against (%) |
|---|---|---|
| Adoption of Financial Statements | 99.99 | 0.01 |
| Appointment of Statutory Auditors | 99.99 | 0.01 |
| Appointment of Secretarial Auditors | 99.99 | 0.01 |
| Reappointment of Nikhil Nanda as MD | 99.76 | 0.24 |
| Approval of Employee Stock Option Scheme 2025 | 99.99 | 0.01 |
These decisions reflect JHS Svendgaard Laboratories' focus on maintaining strong leadership, ensuring robust financial oversight, and aligning employee interests with company growth as it moves forward in the competitive FMCG landscape.
Historical Stock Returns for JHS Svendgaard Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.79% | +2.70% | -4.76% | -21.38% | -58.36% | -44.25% |
18
